Celesia, B.M. et al. 2019. IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Oct. 2019), e2019063. DOI:https://doi.org/10.4084/mjhid.2019.063.